Pamlab Can't Bar Virtus' Marketing In Unfair Competition Row
Law360, New York (December 4, 2013, 5:04 PM EST) -- A Florida federal judge on Tuesday denied Nestle Health Science-Pamlab's bid for a preliminary injunction to block Virtus Pharmaceuticals LLC from marketing a generic version of prescription medical foods, saying the suit is based on unfair competition claims and not harm to patients.
Pamlab had asked the court to block Virtus from selling and distributing its prescription products that Virtus claims to contain certain amounts of the ingredient L-Methylfolate, but which Pamlab says only contain about one-half the amounts represented.
The medical foods product company had argued that Virtus deliberately chose to skip industry-standard testing that is always performed to confirm...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!